Top Clinical Trials companies in Japan by Share Price
Japan
# |
Name |
Share Price |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 21.58 |
Jan. 31, 2025 | USD 21.58 | 0.31% |
|
Japan |
|
| 2 |
USD 10.95 |
Jan. 31, 2025 | USD 10.95 | -0.53% |
|
Japan |
|
| 3 |
USD 5.88 |
Jan. 31, 2025 | USD 5.88 | 7.94% |
|
Japan |
|
| 4 |
USD 5.69 |
Jan. 31, 2025 | USD 5.69 | -0.47% |
|
Japan |
|
| 5 |
USD 4.64 |
Jan. 31, 2025 | USD 4.64 | 0.11% |
|
Japan |
|
| 6 |
USD 3.68 |
Jan. 31, 2025 | USD 3.68 | -3.46% |
|
Japan |
|
| 7 |
USD 2.56 |
Jan. 31, 2025 | USD 2.56 | -2.54% |
|
Japan |
|
| 8 |
USD 2.10 |
Jan. 31, 2025 | USD 2.10 | -1.79% |
|
Japan |
|
| 9 |
USD 2.04 |
Jan. 31, 2025 | USD 2.04 | -2.74% |
|
Japan |
|
| 10 |
USD 1.21 |
Jan. 31, 2025 | USD 1.21 | 1.57% |
|
Japan |
|
| 11 |
USD 0.28 |
Jan. 31, 2025 | USD 0.28 | -0.59% |
|
Japan |
|
| 12 |
USD 0.17 |
Jan. 31, 2025 | USD 0.17 | -10.87% |
|
Japan |
Frequently Asked Questions
-
Which Clinical Trials company in Japan has the highest Share Price ?
The Clinical Trials company in Japan with the highest Share Price is GNI Group Ltd. (Tokyo Stock Exchange: 2160.T) at USD 21.58.
-
Which Clinical Trials company in Japan has the lowest Share Price ?
The Clinical Trials company in Japan with the lowest Share Price is OncoTherapy Science, Inc. (Tokyo Stock Exchange: 4564.T) at USD 0.17.
-
What are the top 10 Clinical Trials companies in Japan by Share Price ?
The top 10 Clinical Trials companies in Japan by Share Price are GNI Group Ltd., Shin Nippon Biomedical Laboratories, Ltd., CanBas Co., Ltd., Cytori Cell Research Institute, Inc., SanBio Company Limited, Oncolys BioPharma Inc., RaQualia Pharma Inc., PhoenixBio Co., Ltd., StemRIM and SymBio Pharmaceuticals Limited.
-
What are the bottom 10 Clinical Trials companies in Japan by Share Price ?
The bottom 10 Clinical Trials companies in Japan by Share Price are OncoTherapy Science, Inc., BrightPath Biotherapeutics Co., Ltd., SymBio Pharmaceuticals Limited, StemRIM, PhoenixBio Co., Ltd., RaQualia Pharma Inc., Oncolys BioPharma Inc., SanBio Company Limited, Cytori Cell Research Institute, Inc. and CanBas Co., Ltd..
